BNIP3L and neoplasm: However, sorafenib resistance in HCCLM3-SR cells (low endogenous expression of BNIP3/BNIP3L) was not reversed by MenSCs, suggesting that the crosstalk between MSCs and tumour cells is also affected by intertumour heterogeneity.